Special items: Ovarian Cancer and Us blog best viewed in Firefox

Tuesday, June 29, 2010

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma - jnl Oncogene

"These data show that cisplatin resistance in HGS (high grade serous) carcinoma develops from pre-existing minor clones but that enrichment for these clones is not apparent during short-term chemotherapy treatment

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.